Phase 2 N=80 Serologic Assay Validation and Proficiency Testing of HIL-214 in Adults
Gastroenteritis
Primary: Primary Immunogenicity for Panel Formation — 87.0; 72.7; 60.5; 98.7 Percentage of Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=31 Characterising the Stable and Dynamic Left Atrial Substrate in Atrial Fibrillation
Atrial Fibrillation
Primary: To Define the Normal Range of Voltage Amplitude — 2.00; 1.92 mV
N/A N=5,696 Screening More Patients for Colorectal Cancer Through Adapting and Refining Targeted Evidence-Based Interventions in Rural Settings, SMARTER CRC
Colorectal Carcinoma
Primary: Likelihood of Any Colorectal Cancer (CRC) Screening (for Study-eligible Patients) — 11.8; 4.5 Percentage of participants
N/A N=34 Effect of Lifestyle Intervention in Patients With Chronic Kidney Disease on Fitness and Immune Function
End-stage Renal Disease (ESRD)
Primary: Peak Oxygen Consumption — 3.07 ml/min/kg
N/A N=18 Validation Study Of A Digital Measuring Device For Central Hand Representation In Children With A Neonatal Brachial Plexus Palsy
Neonatal Brachial Plexus Palsy
Primary: Intrarater Reliability of Implicit Finger Length Estimates Using the HandUZ Device — 0.91; 0.92 Intraclass Correlation Coefficient
Phase 2 N=54 RCT of Fomitopsis Officinalis and Trametes Versicolor to Treat COVID-19
COVID-19
Primary: Total Protein Normal to Abnormal Transition — 0; 0 percentage of participants
Phase 4 N=97 Bowel Function After Minimally Invasive Hysterectomy
Constipation
Primary: Patient Assessment of Constipation Symptoms Questionnaire (PAC-SYM) Score — 1.1; 0.6 score
N/A N=870 Multi-center Trial in Adult and Pediatric Patients With Type 1 Diabetes Using Hybrid Closed Loop System and Control at Home
Type 1 Diabetes
Primary: CSII Cohort: Baseline A1C > 8%: Change in A1C (∆A1C) — -1.6; -0.8 Percentage of HbA1c
Phase 1 N=12 Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya
Cervix Cancer · Cervix Intraepithelial Neoplasia Grade 3 · Cervix; Intraepithelial Neoplasia, Grade I
Primary: To Determine the Area Under the Plasma Concentration Versus Time Curve (AUC) of Dihydroartemisinin — 464.90 ng/mL-h
N/A N=163 Sensory Adapted Dental Environments to Enhance Oral Care for Children
Autism
Primary: Electrodermal Activity (EDA) - Skin Conductance Level (SCL) — 8.96; 7.74 microsiemens (µS) — p=0.01
N/A N=40 Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease) · Uncontrolled Diabetes (HBA1c ≥ 10)
Primary: Physical Functioning Measured Using the Patient-Specific Functional Scale — 7.45; 5.43 score on a scale — p=0.04
Phase 2 N=280 A Phase 2 Bridging Study to Assess the New Formulation of ETVAX
Healty Volunteers · Preventable Disease, Vaccine
Primary: Vaccine Response — 116; 110 Participants
N/A N=11 Evaluation of a Hearing Device for Transmitting Sound to the Inner Ear
Conductive Hearing Loss · Mixed Hearing Loss
Primary: To Assess the Improvement of Hearing With the Sentio1 (PTA4) — 32.5 dB
N/A N=499 Efficacy of an Internet-based Intervention for Dental Anxiety
Dental Anxiety
Primary: Change in Modified Dental Anxiety Scale (MDAS; Humphris et al., 1995). — 19.8; 19.4; 19.4; 16.7 score on a scale
N/A N=98 Chatbot Facilitated Education on Child and Adolescent Abuse
Child Abuse
Primary: Intention to Report Child and Adolescent Abuse and Neglect — 60.77; 61.56; 71.07; 68.29 score on a scale